We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$27.7B
AUM Growth
+$2.29B
Cap. Flow
+$341M
Cap. Flow %
1.23%
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$113M
2
AAPL icon
Apple
AAPL
+$69M
3
PFE icon
Pfizer
PFE
+$57M
4
VZ icon
Verizon
VZ
+$50.4M
5
MSFT icon
Microsoft
MSFT
+$48.6M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$100M
2
LIN icon
Linde
LIN
+$85.1M
3
ABMD
Abiomed Inc
ABMD
+$55.4M
4
RACE icon
Ferrari
RACE
+$51.7M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 27.03%
2 Healthcare 20.96%
3 Financials 10.74%
4 Consumer Discretionary 10.18%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCI icon
51
MSCI
MSCI
$42.6B
$110M 0.4%
237,268
+26,428
+13% +$12.3M
UPS icon
52
United Parcel Service
UPS
$89.3B
$110M 0.4%
632,637
+94,696
+18% +$16.4M
BIIB icon
53
Biogen
BIIB
$30.7B
$107M 0.39%
386,696
+136,991
+55% +$38.7M
EW icon
54
Edwards Lifesciences
EW
$49.4B
$105M 0.38%
1,411,080
+223,287
+19% +$17.2M
FIS icon
55
Fidelity National Information Services
FIS
$24B
$104M 0.38%
1,539,985
-47,557
-3% -$3.38M
TER icon
56
Teradyne
TER
$54.2B
$104M 0.37%
1,188,665
+220,718
+23% +$18.9M
AMT icon
57
American Tower
AMT
$81B
$103M 0.37%
486,771
+29,581
+6% +$6.16M
BSX icon
58
Boston Scientific
BSX
$68.8B
$103M 0.37%
2,227,618
+214,878
+11% +$9.3M
GILD icon
59
Gilead Sciences
GILD
$167B
$101M 0.37%
1,181,167
-297,313
-20% -$23.5M
TJX icon
60
TJX Companies
TJX
$179B
$101M 0.36%
1,267,286
-76,746
-6% -$5.67M
VZ icon
61
Verizon
VZ
$199B
$101M 0.36%
2,559,620
+1,338,538
+110% +$50.4M
AMD icon
62
Advanced Micro Devices
AMD
$731B
$100M 0.36%
1,546,651
+166,371
+12% +$11M
ADSK icon
63
Autodesk
ADSK
$52.1B
$100M 0.36%
535,883
+18,674
+4% +$3.75M
PANW icon
64
Palo Alto Networks
PANW
$260B
$99.9M 0.36%
1,432,022
+101,586
+8% +$8.16M
NKE icon
65
Nike
NKE
$64.7B
$99.7M 0.36%
852,373
-31,552
-4% -$3.18M
VRTX icon
66
Vertex Pharmaceuticals
VRTX
$124B
$99.3M 0.36%
343,690
+66,193
+24% +$20.2M
AXNX
67
DELISTED
Axonics, Inc. Common Stock
AXNX
$99M 0.36%
1,583,386
+40,441
+3% +$2.68M
WCN
68
Waste Connections
WCN
$43.7B
$98.6M 0.36%
743,892
-234,825
-24% -$31.9M
BKNG icon
69
Booking.com
BKNG
$158B
$97.8M 0.35%
1,213,050
-72,500
-6% -$5.5M
AVGO icon
70
Broadcom
AVGO
$1.83T
$97.5M 0.35%
1,744,650
+473,690
+37% +$23.8M
A icon
71
Agilent Technologies
A
$39.7B
$97.2M 0.35%
649,549
+95,869
+17% +$13.7M
APTV icon
72
Aptiv
APTV
$12.5B
$96.9M 0.35%
1,040,179
+14,621
+1% +$1.39M
TRMB icon
73
Trimble
TRMB
$13.8B
$96.1M 0.35%
1,900,458
-66,082
-3% -$3.68M
MRNA icon
74
Moderna
MRNA
$22.1B
$94.6M 0.34%
526,913
+291,235
+124% +$47.6M
BAC icon
75
Bank of America
BAC
$434B
$94.5M 0.34%
2,852,720
+118,997
+4% +$4.1M

Similar funds

Axa's Q4 2022 Portfolio in Review

As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
  • Axa added most to Tesla in Q4 2022, an estimated $113M increase.
  • Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
  • Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
  • Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
  • Axa opened 118 new positions and closed 119 in Q4 2022.
  • Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.